Supplementary Table S5 from Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models | AMiner
Supplementary Table S5 from Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models
Supplementary Table S5. RPPA analysis of phosphorylated and total protein levels in PC9 and NCI-H1975 AZD9291 resistant populations compared to respective parental cells.
原文链接
分享
引用
